Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Healthequity ( (HQY) ) has provided an announcement.
On June 26, 2025, Healthequity held its Annual Meeting where stockholders approved all three proposals, including the election of nine directors and the ratification of PricewaterhouseCoopers LLP as the independent accounting firm. Additionally, the board authorized a new $300 million stock repurchase program, supplementing the previous program, allowing the company to repurchase shares under favorable market conditions.
The most recent analyst rating on (HQY) stock is a Hold with a $108.00 price target. To see the full list of analyst forecasts on Healthequity stock, see the HQY Stock Forecast page.
Spark’s Take on HQY Stock
According to Spark, TipRanks’ AI Analyst, HQY is a Outperform.
Healthequity’s strong financial performance and positive earnings call are the most significant contributors to the overall score. Despite high valuation concerns, the company’s strategic initiatives and potential market expansion position it well for future growth. Mixed technical indicators suggest cautious optimism.
To see Spark’s full report on HQY stock, click here.
More about Healthequity
Average Trading Volume: 1,106,844
Technical Sentiment Signal: Strong Buy
Current Market Cap: $8.99B
For a thorough assessment of HQY stock, go to TipRanks’ Stock Analysis page.